Clinical trial

Efficacy and Safety of Dignicap System for Preventing Chemotherapy Induced Alopecia

NCT01831024

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2013-07-01

PhaseNA

Study timeline

Study start (unknown)2013-07-01Date precision: month

Registry last updated2016-10-19

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Chemotherapy Adjuvantunresolved

Breast Cancerunresolved

Interventions

Dignicap SystemDEVICE

Sponsors & collaborators

Target Health Inc.lead sponsor

Mapped research locations

New YorkNew York, United States2 San FranciscoCalifornia, United States1 Winston-SalemNorth Carolina, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01831024 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.